Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311200) titled 'A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: InventisBio Co., Ltd

Condition: Active Systemic Lupus Erythematosus

Intervention: Drug: D-2570

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 15, 2026

Target Sample Size: 120

To know more, visit https://clinicaltrials.gov/study/NCT07311200

Di...